UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 82 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $74,000 | – | 21,390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
| Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
| Leap Investments LP | 13,400 | $78,000 | 0.11% |
| Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
| Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
| Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
| Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
| SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
| Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |